Content about Pharmacist Society

June 18, 2013

Avella Specialty Pharmacy will be included in the limited distribution network for a cancer drug made by Genentech, Avella said Tuesday.

PHOENIX — Avella Specialty Pharmacy will be included in the limited-distribution network for a cancer drug made by Genentech, Avella said Tuesday.

The specially pharmacy company said it would be included in the network to sell Tarceva (erlotinib), an orally administered drug used to treat non-small cell lung cancer and pancreatic cancer. Genentech will shift distribution of Tarceva to a select group of pharmacies starting July 1 to align its distribution with that of similar cancer drugs.

June 18, 2013

The Food and Drug Administration's Center for Drug Evaluation and Research has collected 84% of the fees it intends to collect this year under a law passed last year to collect user fees from generic drug members, according to a memo sent out to CDER staff Tuesday.

NEW YORK — The Food and Drug Administration's Center for Drug Evaluation and Research has collected 84% of the fees it intends to collect this year under a law passed last year to collect user fees from generic drug members, according to a memo sent out to CDER staff Tuesday.

CDER director Janet Woodcock wrote that the FDA had collected more than $255 million under the Generic Drug User Fee Amendments to the 2012 Prescription Drug User Fee Act reauthorization. The agency plans to collect $299 million in fiscal year 2013.

June 18, 2013

Spending on health care will slow down in 2014 despite a flood of new patients who will have insurance, according to a new study.

NEW YORK — Spending on health care will slow down in 2014 despite a flood of new patients who will have insurance, according to a new study.

The PwC Health Research Institute study, titled Medical Cost Trend: Behind the Numbers, forecasts 6.5% inflation in healthcare spending despite the Patient Protection and Affordable Care Act adding millions of new patients. The report noted that the slowdown in spending was contrary to the experience of previous recessions.

June 18, 2013

A division of Mylan is hiring NFL player Adrian Peterson and family expert Jo Frost to promote an emergency treatment for severe allergic reactions.

BASKING RIDGE, N.J. — A division of Mylan is hiring NFL player Adrian Peterson and celebrity nanny Jo Frost to promote an emergency treatment for severe allergic reactions.

Mylan Specialty announced that it had hired the two — who both have potentially life-threatening allergies — to raise awareness of the problem. Mylan Specialty is launching a multichannel marketing campaign for the EpiPen (epinephrine) auto-injector to mark the 25th anniversary of its approval by the Food and Drug Administration.

June 18, 2013

Royalty Pharma will not buy Irish drug maker Elan Corp., the company said Tuesday.

NEW YORK — Royalty Pharma will not buy Irish drug maker Elan Corp., the company said Tuesday.

Royalty said it would withdraw a request for a review by the Irish Takeover Panel after Elan shareholders voted in favor of a share buyback. Elan said last week that it would begin a process of selling itself to Royalty, which had previously offered $13 per share for the company.

June 18, 2013

Teva Pharmaceutical Industries will spend up to $165 million to buy a company developing a drug to prevent viral respiratory infections.

JERUSALEM — Teva Pharmaceutical Industries will spend up to $165 million to buy a company developing a drug to prevent viral respiratory infections.

Teva said it would acquire MicroDose Therapeutx for $40 million, plus up to $125 million in milestone payments and sales milestones and royalties from its lead product, MDT-637, an inhaled treatment for respiratory syncytial virus, or RSV.

June 18, 2013

Half a loaf, the saying goes, is better than none. For the generic drug industry, that means that the Supreme Court handed it a partial victory Monday by ruling that “pay for delay” patent settlements between brand name and generic drug companies aren’t necessarily illegal and should be considered on a case-by-case, “rule of reason” approach by the Federal Trade Commission, which staunchly opposes the practice.

Half a loaf, the saying goes, is better than none. For the generic drug industry, that means that the Supreme Court handed it a partial victory Monday by ruling that “pay for delay” patent settlements between brand name and generic drug companies aren’t necessarily illegal and should be considered on a case-by-case, “rule of reason” approach by the Federal Trade Commission, which staunchly opposes the practice.

June 17, 2013

BioScrip will acquire a Cincinnati-based home infusion company for $223 million, BioScrip said Monday.

ELMSFORD, N.Y. — BioScrip will acquire a Cincinnati-based home infusion company for $223 million, BioScrip said Monday.

June 17, 2013

Drug maker Johnson & Johnson plans to spend up to $1 billion to acquire a privately owned company developing a drug for prostate cancer.

NEW BRUNSWICK, N.J. — Drug maker Johnson & Johnson plans to spend up to $1 billion to acquire a privately owned company developing a drug for prostate cancer.

J&J said Monday it would acquire Aragon Pharmaceuticals for $650 million upfront plus up to $350 million in milestone payments, with the expectation that the deal will close in third quarter 2013.

June 17, 2013

Perrigo Co. will pay up to $129 million to buy Fera Pharmaceuticals' portfolio of ophthalmic products, Perrigo said.

ALLEGAN, Mich. — Perrigo Co. will pay up to $129 million to buy Fera Pharmaceuticals' portfolio of ophthalmic products, Perrigo said Monday.

Perrigo said the acquisition from Locust Valley, N.Y.-based Fera included an upfront payment of $93 million and milestone payments of about $36 million. The products include generic ophthalmic sterile ointments and solutions and generated sales of more than $30 million in 2012.

June 17, 2013

Patent settlements between brand and generic drug makers commonly referred to as "pay-for-delay" settlements are not necessarily against the law, the Supreme Court ruled Monday.

NEW YORK — Patent settlements between brand and generic drug makers commonly referred to as "pay-for-delay" settlements are not necessarily against the law, the Supreme Court ruled Monday.

June 17, 2013

Walgreens today announced a donation to the Pan American Health Organization to help make 35,000 doses of flu vaccine available to at-risk populations in Laos and Nicaragua, building upon a successful public-private initiative to help create greater access to seasonal flu vaccine in developing countries.

DEERFIELD, Ill. — Walgreens today announced a donation to the Pan American Health Organization to help make 35,000 doses of flu vaccine available to at-risk populations in Laos and Nicaragua, building upon a successful public-private initiative to help create greater access to seasonal flu vaccine in developing countries.

June 14, 2013

Irish drug maker Elan Corp. said Friday it was looking to sell itself off to a New York-based company that invests in drug royalties after rejecting a previous offer.

DUBLIN — Irish drug maker Elan Corp. said Friday it was looking to sell itself off to a New York-based company that invests in drug royalties after rejecting a previous offer.

The company said it would start a process to be acquired by Royalty Pharma, but that shareholders should not put their shares up for sale into another, hostile takeover attempt by Royalty, in which Royalty offered more than $7.7 billion, or $13 per share, plus $2.50 in milestone payments. Elan has rejected that offer, made last week.

June 13, 2013

Drug maker Actavis is working with nonprofit pharmaceutical company Medicines360 to make low-cost intrauterine devices available to women, the two said.

PARSIPPANY, N.J. — Drug maker Actavis is working with nonprofit pharmaceutical company Medicines360 to make low-cost intrauterine devices available to women, the two said.

June 13, 2013

Regional drug store chain Bartell Drugs is looking for a volunteer to represent it in a bike ride to raise money for a local cancer-research center.

SEATTLE — Regional drug store chain Bartell Drugs is looking for a volunteer to represent it in a bike ride to raise money for a local cancer research center.

Bartell said that through June 22, it would accept entries in a contest for a rider to represent it in Obliteride, which has the goal of enlisting 2,500 bike riders and 1,000 volunteers to raise $2.5 million for the Fred Hutchinson Cancer Research Center in Seattle.

June 13, 2013

Emdeon has bought a company that provides pharmacy benefit and related services to state Medicaid agencies, Emdeon said.

NASHVILLE, Tenn. — Emdeon has bought a company that provides pharmacy benefit and related services to state Medicaid agencies, Emdeon said.

Emdeon announced the acquisition of Goold Health Systems. Financial terms of the deal were not disclosed.

"The acquisition expands Emdeon's position in the government pharmacy benefit administration market while enhancing our existing pharmacy benefit operations," Emdeon EVP pharmacy services Kevin Mahoney said.

 

June 13, 2013

The Food and Drug Administration has approved a drug made by Amgen for treating a rare and usually noncancerous bone tumor, the agency said Thursday.

SILVER SPRING, Md. – The Food and Drug Administration has approved a drug made by Amgen for treating a rare and usually noncancerous bone tumor, the agency said Thursday.

June 13, 2013

Most of the growth in jobs in the healthcare sector comes from home health care, according to data released this month by the Bureau of Labor Statistics.

WASHINGTON — Most of the growth in jobs in the healthcare sector comes from home health care, according to data released this month by the Bureau of Labor Statistics.

June 13, 2013

A state legislator in Ohio is sponsoring an open-house event to demonstrate advances in telemedicine.

COLUMBUS, Ohio — A state legislator in Ohio is sponsoring an open-house event to demonstrate advances in telemedicine.

June 12, 2013

Avella Specialty Pharmacy has released a new white paper for payers selecting new specialty pharmacy partners, the company said Wednesday.

PHOENIX — Avella Specialty Pharmacy has released a new white paper for payers selecting new specialty pharmacy partners, the company said Wednesday.

June 12, 2013

Meijer will open two new stores in northern Indiana, the mass merchandise retailer said.

GRAND RAPIDS, Mich. — Meijer will open two new stores in northern Indiana, the mass merchandise retailer said Wednesday.

Meijer said the stores, in Portage and Warsaw, Ind., would open on Thursday. The Grand Rapids, Mich.-based chain currently operates 32 stores around the state and more than 200 throughout the Midwest. The company said the stores would feature the chain's free prescription program, whereby it gives select drugs for free to customers with valid prescriptions, including generic versions of the cholesterol drug Lipitor (atorvastatin).

June 12, 2013

Google has removed advertisements for websites that sell drugs without prescriptions, following a series of warning letters from a state attorney general, according to published reports.

NEW YORK — Google has removed advertisements for websites that sell drugs without prescriptions, following a series of warning letters from a state attorney general, according to published reports.

June 12, 2013

More than 200 drugs are under development for cardiovascular disease, according to a drug industry trade group.

WASHINGTON — More than 200 drugs are under development for cardiovascular disease, according to a drug industry trade group.

June 12, 2013

Pharmacy automation provider QS/1 has received certification for controlled substances prescribed electronically, the company said.

SPARTANBURG, S.C. — Pharmacy automation provider QS/1 has received certification for controlled substances prescribed electronically, the company said.

QS/1 said it received Electronic Prescriptions for Control Substances certification, making it one of the first pharmacy vendors to certify for EPCS in the 10.6 Script Standard.

June 12, 2013

Rite Aid will offer free informational resources in its stores and online on summer skin care, as well as sponsoring a cross-country tour offering full-body skin cancer screenings, the drug store chain said Wednesday.

CAMP HILL, Pa. — Rite Aid will offer free informational resources in its stores and online on summer skin care, as well as sponsoring a cross-country tour offering full-body skin cancer screenings, the drug store chain said Wednesday.

Rite Aid is partnering with the Skin Cancer Foundation for the program, which will last through July. A study published in the June edition of the Annals of Internal Medicine indicated that proper sun protection can keep skin looking younger as well as healthier.